全文获取类型
收费全文 | 1100366篇 |
免费 | 75719篇 |
国内免费 | 3020篇 |
专业分类
耳鼻咽喉 | 15268篇 |
儿科学 | 34893篇 |
妇产科学 | 28959篇 |
基础医学 | 156715篇 |
口腔科学 | 29989篇 |
临床医学 | 98500篇 |
内科学 | 207921篇 |
皮肤病学 | 24605篇 |
神经病学 | 83154篇 |
特种医学 | 44032篇 |
外国民族医学 | 225篇 |
外科学 | 165994篇 |
综合类 | 25651篇 |
现状与发展 | 6篇 |
一般理论 | 279篇 |
预防医学 | 76415篇 |
眼科学 | 25171篇 |
药学 | 88844篇 |
19篇 | |
中国医学 | 4082篇 |
肿瘤学 | 68383篇 |
出版年
2021年 | 8796篇 |
2019年 | 8584篇 |
2018年 | 12237篇 |
2017年 | 9728篇 |
2016年 | 10929篇 |
2015年 | 12519篇 |
2014年 | 16723篇 |
2013年 | 23498篇 |
2012年 | 32650篇 |
2011年 | 34459篇 |
2010年 | 20341篇 |
2009年 | 18939篇 |
2008年 | 31504篇 |
2007年 | 33664篇 |
2006年 | 34306篇 |
2005年 | 32532篇 |
2004年 | 30914篇 |
2003年 | 29765篇 |
2002年 | 28571篇 |
2001年 | 60555篇 |
2000年 | 61967篇 |
1999年 | 51393篇 |
1998年 | 12748篇 |
1997年 | 11328篇 |
1996年 | 11286篇 |
1995年 | 10576篇 |
1994年 | 9561篇 |
1993年 | 9011篇 |
1992年 | 37972篇 |
1991年 | 36423篇 |
1990年 | 35863篇 |
1989年 | 34368篇 |
1988年 | 30945篇 |
1987年 | 30057篇 |
1986年 | 28272篇 |
1985年 | 26506篇 |
1984年 | 19238篇 |
1983年 | 16134篇 |
1982年 | 8846篇 |
1979年 | 17042篇 |
1978年 | 11415篇 |
1977年 | 10238篇 |
1976年 | 8842篇 |
1975年 | 10069篇 |
1974年 | 11660篇 |
1973年 | 11281篇 |
1972年 | 10756篇 |
1971年 | 10096篇 |
1970年 | 9253篇 |
1969年 | 8938篇 |
排序方式: 共有10000条查询结果,搜索用时 328 毫秒
51.
Xiaoyan Lu Isabelle R. Miousse Sandra V. Pirela Jodene K. Moore Stepan Melnyk 《Nanotoxicology》2016,10(5):629-639
Evidence continues to grow on potential environmental health hazards associated with engineered nanomaterials (ENMs). While the geno- and cytotoxic effects of ENMs have been investigated, their potential to target the epigenome remains largely unknown. The aim of this study is two-fold: 1) determining whether or not industry relevant ENMs can affect the epigenome in vivo and 2) validating a recently developed in vitro epigenetic screening platform for inhaled ENMs. Laser printer-emitted engineered nanoparticles (PEPs) released from nano-enabled toners during consumer use and copper oxide (CuO) were chosen since these particles induced significant epigenetic changes in a recent in vitro companion study. In this study, the epigenetic alterations in lung tissue, alveolar macrophages and peripheral blood from intratracheally instilled mice were evaluated. The methylation of global DNA and transposable elements (TEs), the expression of the DNA methylation machinery and TEs, in addition to general toxicological effects in the lung were assessed. CuO exhibited higher cell-damaging potential to the lung, while PEPs showed a greater ability to target the epigenome. Alterations in the methylation status of global DNA and TEs, and expression of TEs and DNA machinery in mouse lung were observed after exposure to CuO and PEPs. Additionally, epigenetic changes were detected in the peripheral blood after PEPs exposure. Altogether, CuO and PEPs can induce epigenetic alterations in a mouse experimental model, which in turn confirms that the recently developed in vitro epigenetic platform using macrophage and epithelial cell lines can be successfully utilized in the epigenetic screening of ENMs. 相似文献
52.
53.
54.
目的 分析社区"5+1"糖尿病分阶段达标管理对2型糖尿病患者生存质量的干预效果及其影响因素,为提高患者生存质量提供依据。方法 采用分层整群抽样的方法在山西省、江苏省和宁夏回族自治区选择12个社区卫生服务中心,分别作为干预组(管理方式:社区"5+1"糖尿病分阶段达标管理)、对照组[管理方式:依据《国家基本公共卫生服务规范(2011年版)》的相关要求],进行为期2年的随访观察。采用面对面问卷调查的方式,收集患者的人口学信息等基本信息;采用健康调查简表(SF-36)对患者在干预前后测量生存质量。采用SAS 9.4软件进行双重差分法以及多重线性回归模型分析。结果 基线时共纳入2 467名研究对象,终末时共1 924人接受了为期2年完整的随访管理。干预后,干预组、对照组患者生理健康维度(PCS)、心理健康维度(MCS)评分变化净差值分别为13.6分、29.8分。多重线性回归分析结果显示,影响患者PCS得分的主要因素有年龄、医保类型、基线PCS得分以及所在地区,影响患者MCS得分的主要因素有年龄、医保类型、基线MCS得分、是否合并高血压以及所在地区。结论 社区"5+1"糖尿病分阶段达标管理对2型糖尿病患者生存质量的干预效果较好。 相似文献
55.
56.
57.
T. Wu L. G. Trahair M. J. Bound C. F. Deacon M. Horowitz C. K. Rayner K. L. Jones 《Diabetic medicine》2015,32(5):595-600
58.
Harit Kapoor Kush Raj Lohani Tommy H. Lee Devendra K. Agrawal Sumeet K. Mittal 《CTS Clinical and Translational Science》2015,8(6):841-847
Esophageal adenocarcinoma is the fastest rising cancer in the United States. It develops from long‐standing gastroesophageal reflux disease which affects >20% of the general population. It carries a very poor prognosis with 5‐year survival <20%. The disease is known to sequentially progress from reflux esophagitis to a metaplastic precursor, Barrett''s esophagus and then onto dysplasia and esophageal adenocarcinoma. However, only few patients with reflux develop Barrett''s esophagus and only a minority of these turn malignant. The reason for this heterogeneity in clinical progression is unknown. To improve patient management, molecular changes which facilitate disease progression must be identified. Animal models can provide a comprehensive functional and anatomic platform for such a study. Rats and mice have been the most widely studied but disease homology with humans has been questioned. No animal model naturally simulates the inflammation to adenocarcinoma progression as in humans, with all models requiring surgical bypass or destruction of existing antireflux mechanisms. Valuable properties of individual models could be utilized to holistically evaluate disease progression. In this review paper, we critically examined the current animal models of Barrett''s esophagus, their differences and homologies with human disease and how they have shaped our current understanding of Barrett''s carcinogenesis. 相似文献
59.
60.